Bhole Baba Biogenics Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 29-05-2024
- Paid Up Capital ₹ 6.75 M
as on 29-05-2024
- Company Age 20 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
About Bhole Baba Biogenics
The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 6.75 M, as per Ministry of Corporate Affairs (MCA) records.
Sangeeta Agarwal and Meena Agarwal serve as directors at the Company.
- CIN/LLPIN
U24233UP2004PTC028660
- Company No.
028660
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 May 2004
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Agra, Uttar Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Bhole Baba Biogenics?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sangeeta Agarwal  | Director | 19-Mar-2014 | Current |
| Meena Agarwal | Director | 19-Mar-2014 | Current |
Financial Performance and Corporate Structure Insights of Bhole Baba Biogenics.
Bhole Baba Biogenics Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Bhole Baba Biogenics?
In 2017, Bhole Baba Biogenics had a promoter holding of 2.22% and a public holding of 97.78%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Bholeshankar Finsec Private LimitedActive 26 years 9 monthsSangeeta Agarwal and Meena Agarwal are mutual person
- Hare Krishna Finsec Private LimitedActive 25 years 6 months
Sangeeta Agarwal and Meena Agarwal are mutual person
- Shyamji Hotels And Buildcon Private LimitedActive 14 years 5 months
Sangeeta Agarwal and Meena Agarwal are mutual person
- Deer Buildtech Private LimitedActive 14 years 7 days
Sangeeta Agarwal and Meena Agarwal are mutual person
- Stable Buildcom Private LimitedActive 13 years 11 months
Sangeeta Agarwal and Meena Agarwal are mutual person
- Radhey Shyam Infracity Private LimitedActive 13 years 7 months
Sangeeta Agarwal and Meena Agarwal are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Bhole Baba Biogenics?
Unlock and access historical data on people associated with Bhole Baba Biogenics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bhole Baba Biogenics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bhole Baba Biogenics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
